View of The Evolution of Lymphangioleiomyomatosis (LAM) Management: From Hormonal Manipulation to Targeted Inhibition of the mammalian target of rapamycin (mTOR) Pathway

Return to Article Details The Evolution of Lymphangioleiomyomatosis (LAM) Management: From Hormonal Manipulation to Targeted Inhibition of the mammalian target of rapamycin (mTOR) Pathway Download Download PDF